European Pharmaceutical Review

MARCH 14, 2024

Overall, the goal of expanded facility is to strengthen [SK biosciences] manufacturing capabilities for global supply [of the pneumococcal conjugate vaccine candidate GBP410]” SK bioscience has announced its manufacturing plant L HOUSE, in Andong, Gyeongsangbuk-do, South Korea, is set to have a facility expansion.

Manufacturing 85

Manufacturing Marketing Medicine Pharma 85

European Pharmaceutical Review

FEBRUARY 27, 2024

It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen.

Manufacturing 100

Manufacturing Food and Drug Administration Food Networking 100

Pharmaceutical Technology

APRIL 12, 2024

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

Manufacturing 98

Manufacturing 98

European Pharmaceutical Review

DECEMBER 21, 2023

Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. We see the market gravitating towards large and commercial scale manufacturing, which the new facility is well equipped to address,” he added.

Manufacturing 88

Manufacturing Government Pharma Marketing 88

European Pharmaceutical Review

NOVEMBER 24, 2023

Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint. As “a future-proof and cost-effective facility”, Novo Nordisk stated that it will reduce water consumption by 25 percent compared to current production lines.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 96

PharmaTech

APRIL 1, 2024

Pharmaceutical Technology gives a brief overview of some of developments in manufacturing facilities, including news from W.R. Grace & Co, ITT Inc, and SMC.

Manufacturing 52

Manufacturing Pharmaceutical 52

PharmaTech

APRIL 19, 2024

New regulations, including those put forth by Annex 1, require many pharmaceutical manufacturers to rethink their facility designs to promote compliance.

Pharmaceutical manufacturing 72

Pharmaceutical manufacturing Manufacturing Pharmaceutical 72

Fierce Pharma

MAY 1, 2024

Just about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the CDMO-turned-biopharma company. Merely about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the CDMO-turned-biopharma company.

Biopharma 271

Biopharma 271

PharmaTimes

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Leads 92

Leads Electronics Medicine 92

European Pharmaceutical Review

SEPTEMBER 12, 2023

A new state-of-the-art manufacturing facility for microbiome ecosystem therapies has now completed construction. The new facility was completed within 12 months, according to David Lescuyer, CEO and President of Skyepharma. The post Microbiome therapy manufacturing facility completed appeared first on European Pharmaceutical Review.

Manufacturing 92

Manufacturing Pharma Pharmaceutical Leads 92

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. Partly due to this and due to the explorative phase cell therapy is in, it is very expensive to develop and manufacture cell therapies, so there simply are not many facilities doing it.”

Manufacturing 109

Manufacturing Leads Networking Pharmaceutical 109

PharmaTech

APRIL 26, 2024

As breakthrough therapeutics in the pharma pipeline approach commercialization, pharmaceutical manufacturing facilities must evolve to meet demand.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Manufacturing Pharma Pharmaceutical 59

Pharmaceutical Technology

MARCH 13, 2024

Bright Green has announced plans to expand its controlled substances drug production facility in New Mexico, US with an investment of $250m.

97

97

European Pharmaceutical Review

DECEMBER 15, 2023

Alkermes has agreed to sell its pharmaceutical development and manufacturing facility in Athlone, Ireland to Novo Nordisk for $92.5 Additionally, Alkermes and Novo Nordisk plan to agree subcontracting arrangements to continue certain work currently performed at the facility, potentially until the end of 2025.

Manufacturing 84

Manufacturing Engineering Pharmaceutical 84

Pharmaceutical Technology

FEBRUARY 7, 2024

AstraZeneca is investing $300m in a facility in Rockville, US - a significant step in launching its cell therapy platforms in the country.

97

97

European Pharmaceutical Review

JULY 8, 2022

As established facilities age, various risk considerations emerge. While some risks related to the processes and facilities becoming obsolete or incremental modifications over time making production less efficient, he also included microbial contamination concerns, which will be the focus of this summary.

Pharmaceutical 123

Pharmaceutical Management 123

Pharmaceutical Technology

DECEMBER 21, 2023

Genevoyager has announced the opening of contract development and manufacturing organisation facility to manufacture gene therapy products.

Manufacturing 97

Manufacturing 97

European Pharmaceutical Review

OCTOBER 17, 2023

The US Food and Drug Administration (FDA) has published draft guidance on how it intends to use alternative tools for assessing drug manufacturing facilities identified in pending marketing applications. Fundamentally, this approach will establish whether facilities meet applicable requirements for FDA approval and licensure decisions.

FDA 93

FDA Food and Drug Administration Manufacturing Food 93

pharmaphorum

JANUARY 25, 2024

UK government is reported to be considering financial aid for AstraZeneca to seal a deal to expand a vaccines manufacturing facility in Speke

Government 98

Government Manufacturing 98

Pharmaceutical Technology

NOVEMBER 24, 2023

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

Manufacturing 105

Manufacturing 105

Fierce Pharma

OCTOBER 10, 2023

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies.

Prospecting 284

Prospecting Manufacturing Medicine Leads 284

European Pharmaceutical Review

JUNE 9, 2023

Telix Pharmaceuticals has opened a new radiopharma production facility in the Wallonia region of Belgium, which will serve as the company’s primary manufacturing site for radioisotopes and commercial and clinical products. Telix is also preparing to install the first of two planned cyclotrons for the radiopharma production facility.

Manufacturing 83

Manufacturing Transportation Government Pharmaceutical 83

MedCity News

DECEMBER 12, 2022

It may take some time to introduce VR into your skilled nursing facility, but it will be worth it for the physical, mental, and social benefit of your residents.

Training 145

Training Medical 145

PharmaTech

APRIL 22, 2024

A panel of experts went over new regulatory requirements for contamination control and gave guidance on implementing a contamination control strategy in cell and gene therapy facilities at INTERPHEX 2024.

52

52

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year.

Government 140

Government Manufacturing Pharmaceutical Marketing 140

European Pharmaceutical Review

SEPTEMBER 13, 2023

Following a UK Medicines & Healthcare Products Regulatory Agency (MHRA) inspection, Rentschler Biopharma SE’s UK advanced therapy medicinal products (ATMP) facility has received a current good manufacturing practice (cGMP) Manufacturing Compliance Certificate.

Biopharma 82

Biopharma Manufacturing Medicine Healthcare 82

pharmaphorum

NOVEMBER 23, 2023

US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.

Government 93

Government 93

Fierce Pharma

FEBRUARY 26, 2024

Bristol Myers Squibb’s first drug substance facility outside the United States is now set to become the company’s inaugural sterile drug product (SDP) facility in Europe, thanks to a multi-million- | Bristol Myers Squibb’s first drug substance facility outside the United States is now set to become the company’s inaugural sterile drug product (SDP) (..)

287

287

European Pharmaceutical Review

FEBRUARY 3, 2023

Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. The 9,500m 2 facility will harness state-of-the-art containment technologies, Baduel confirmed.

Manufacturing 93

Manufacturing Pharmaceutical Marketing Sales 93

European Pharmaceutical Review

JULY 26, 2023

A Finnish contract development and manufacturing organisation (CDMO) specialising in biopharmaceuticals, has announced it is investing over €50 million to expand its manufacturing facility in Turku, Finland. The size of the new facility will be 6,400m 2 (69,000ft 2 ). The new facility is expected to be fully operational by 2025.

Manufacturing 68

Manufacturing Medicine Pharmaceutical 68

European Pharmaceutical Review

JULY 21, 2023

It also adds to news of the intended expansion of the firm’s biosimilar development capabilities at its facility in Holzkirchen, Germany in May 2023. AI-driven biosimilar manufacturing partnership announced The post Sandoz to build Slovenian biosimilar development facility appeared first on European Pharmaceutical Review.

Biopharma 91

Biopharma Manufacturing Competition Healthcare 91

European Pharmaceutical Review

FEBRUARY 15, 2024

The Nelson Labs Itasca facility is current good manufacturing practice (cGMP) compliant and is a fully accredited pharmaceutical testing laboratory that complements global pharmaceutical services provided by Nelson Labs sites in Salt Lake City, Utah in this US, and Leuven, Belgium.

Manufacturing 90

Manufacturing Pharmaceutical Safety Pharma 90

Pharmaceutical Technology

MARCH 31, 2023

Moderna has finalised an agreement with the government of the Republic of Kenya to establish an mRNA manufacturing facility in the country. The company is also committed to establishing mRNA manufacturing facilities in Australia, Canada, the US and the UK.

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

PharmaTech

SEPTEMBER 25, 2023

The Novo Nordisk Foundation will invest up to DKK 950 million (€127 million, US$136 million) in a new cell therapy manufacturing facility in Lyngby, Denmark.

Manufacturing 98

Manufacturing 98

pharmaphorum

OCTOBER 10, 2023

Bayer backs cell therapy ambition with $250m US facility Phil.Taylor Tue, 10/10/2023 - 08:49 Bookmark this

92

92

European Pharmaceutical Review

MARCH 28, 2023

Eli Lilly and Company will double its investment to nearly $1 billion at its new biologics drug manufacturing facility, in Raheen, Limerick, stated Ireland’s Industrial Development Agency (IDA). Moreover, Eli Lilly stated it has plans to support green manufacturing by responsibly managing water used at the site and facility.

Manufacturing 73

Manufacturing Medicine Engineering Pharmaceutical 73

Pharmaceutical Technology

JUNE 27, 2023

Vertex and Lonza have entered a partnership to establish a facility in Portsmouth, US, to manufacture cell therapies for type 1 diabetes.

Manufacturing 98

Manufacturing 98